Search

Boston Scientific Corp.

Затворен

СекторЗдравеопазване

51.81 0.12

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

51.68

Максимум

52.75

Ключови измерители

By Trading Economics

Приходи

-437M

904M

Продажби

239M

5.4B

P/E

Средно за сектора

19.945

57.002

EPS

0.86

Марж на печалбата

16.612

Служители

59,000

EBITDA

-214M

1.4B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+20.41% upside

Дивиденти

By Acuity

Следващи печалби

28.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

5.5B

73B

Предишно отваряне

51.69

Предишно затваряне

51.81

Настроения в новините

By Acuity

41%

59%

144 / 340 Класиране в Healthcare

Boston Scientific Corp. Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.08.2026 г., 23:01 ч. UTC

Boston Scientific Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions finishing higher. No specific news was identified.

13.08.2026 г., 23:01 ч. UTC

Social Media

Boston Scientific shares are higher in after-market trading, buoyed by social media discussions of the CEO's $9 million stock purchase amid a significant year-to-date decline.

12.08.2026 г., 23:06 ч. UTC

Boston Scientific Corp shares are modestly higher in after-market trading. The stock remains significantly above its 20-day moving average.

11.08.2026 г., 23:41 ч. UTC

Boston Scientific Corp shares are lower in after-market trading, showing unusual volatility and reflecting a broader trend of weakness since Tuesday's close.

10.08.2026 г., 23:06 ч. UTC

Boston Scientific shares are trading higher in after-market hours, amid mixed market sentiment influenced by geopolitical tensions, particularly concerning the Strait of Hormuz.

8.08.2026 г., 00:01 ч. UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting gains since Friday's close and remaining above their 20-day moving average.

7.08.2026 г., 23:21 ч. UTC

Boston Scientific shares are higher in after-market hours following a Labor Department report showing a decline in non-farm payroll employment, reducing interest rate hike expectations.

6.08.2026 г., 23:01 ч. UTC

Boston Scientific Corp shares are higher during after-market hours, reflecting a generally strong performance backdrop amid resilient labor market data.

5.08.2026 г., 23:02 ч. UTC

Social Media
News

Boston Scientific Corp shares rose in after-market trading following CEO Mahoney's purchase of 186,240 shares at an average price of $48.33.

4.08.2026 г., 19:36 ч. UTC

News

Boston Scientific shares are higher, supported by strong organic revenue growth and rising free cash flow margin, despite recent economic data pressures.

3.08.2026 г., 23:01 ч. UTC

Boston Scientific Corp shares are higher in after-market hours, reflecting positive momentum. Broader economic news shows increased growth in the manufacturing sector.

31.07.2026 г., 22:52 ч. UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting positive market sentiment from strong earnings by major tech companies.

30.07.2026 г., 23:51 ч. UTC

News

Boston Scientific shares are higher in after-market trading following UBS's Buy rating and a price target adjustment to $67 amid Penumbra's results.

29.07.2026 г., 23:51 ч. UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting broader market gains. No specific news has been identified to explain the movement.

28.07.2026 г., 23:52 ч. UTC

Boston Scientific Corp shares are higher in after-market hours, reflecting a steady increase since Tuesday's close despite broader market concerns, particularly in Asia.

27.07.2026 г., 23:02 ч. UTC

News
Social Media

Boston Scientific plans a restructuring with pre-tax charges of $700 million to $800 million, leading shares lower in after-market hours.

25.07.2026 г., 00:01 ч. UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

24.07.2026 г., 23:01 ч. UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

22.07.2026 г., 20:06 ч. UTC

Correlated Moves

Boston Scientific reported first-quarter adjusted EPS of $0.43, missing estimates. Shares are trading lower amid cautious market sentiment and Stryker's decline.

21.07.2026 г., 23:06 ч. UTC

Boston Scientific Corp shares are higher in after-hours trading, reflecting a modest uptick following Tuesday's close. The stock remains below its 20-day moving average.

20.07.2026 г., 23:01 ч. UTC

Boston Scientific shares are higher in after-market trading, reflecting notable strength since Monday's close, despite no specific news driving the movement.

Сравнение с други в отрасъла

Ценова промяна

Boston Scientific Corp. Прогноза

Ценова цел

By TipRanks

20.41% нагоре

12-месечна прогноза

Среден 62.41 USD  20.41%

Висок 89 USD

Нисък 50 USD

Според 24 анализатори от Wall Street, предложили 12-месечна ценова цел за Boston Scientific Corp. през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

24 ratings

21

Купи

3

Задържане

0

Продай

Настроение

By Acuity

144 / 340 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
help-icon Live chat